Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- CIT-013 dosePhase 22 trials
Citryll BV · Hidradenitis Suppurativa (HS), Rheumatoid Arthritis
- CNMAu8gold nanocrystalsPhase 22 trials
Clene Nanomedicine · Amyotrophic Lateral Sclerosis, Multiple Sclerosis
- COH04S1GEO-CM04S1, Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1Phase 22 trials
GeoVax, Inc. · COVID-19 Infection, Hematopoietic and Lymphoid System Neoplasm, Leukemia
- CRC01Phase 22 trials
Curocell Inc. · Relapsed Large B-cell Lymphoma, Refractory Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL)
- CRD-4730Phase 22 trials
Cardurion Pharmaceuticals, Inc. · Catecholaminergic Polymorphic Ventricular Tachycardia, Heart Failure With Reduced Ejection Fraction (HFrEF)
- CS-1103Phase 22 trials
Clear Scientific, Inc. · Methamphetamine Intoxication, Methamphetamine Disorders, Methamphetamine Abuse
- CT1812Study Drug ActivePhase 22 trials
Cognition Therapeutics · Early Alzheimer's Disease, Dementia With Lewy Bodies
- CusatuzumabOV-1001, JNJ-74494550Phase 22 trials
OncoVerity, Inc. · Leukemia, Myeloid, Acute
- CVL006Phase 22 trials
Convalife (Shanghai) Co., Ltd. · Advanced Solid Tumor
- CVL237Phase 22 trials
Convalife (Shanghai) Co., Ltd. · Advanced Solid Tumors, Locally Advanced or Metastatic Solid Tumors, PTEN Loss or Low Expression
- CVM-1118TRX-818Phase 22 trials
TaiRx, Inc. · Hepatocellular Carcinoma, Advanced Cancer, Neuroendocrine Tumors
- CVXGACVXGA50, PIV5-SARS CoV-2Phase 22 trials
CyanVac LLC · COVID-19
- CYH33Phase 22 trials
Haihe Biopharma Co., Ltd. · PIK3CA-Related Overgrowth Spectrum (PROS), PIK3CA-related Vascular Malformations (PRVM), Ovarian Cancer
- D3S-001Phase 22 trials
D3 Bio (Wuxi) Co., Ltd · Advanced Solid Tumors With MAPK Pathway Mutations, KRAS P.G12C
- DactolisibBEZ235, RTB101Phase 22 trials
Restorbio Inc. · Respiratory Tract Infections, Covid19
- DanburstotugIMC-001Phase 22 trials
ImmuneOncia Therapeutics Inc. · TMB-H, Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors, Extranodal NK/T-cell Lymphoma, Nasal Type
- DB-1305BNT325Phase 22 trials
DualityBio Inc. · Solid Tumors, Advanced Solid Tumor
- DB-3QPhase 22 trials
Direct Biologics, LLC · Perianal Fistula Due to Crohn's Disease, Crohn Disease (CD)
- DelamanidPhase 22 trials
WestVac Biopharma Co., Ltd. · Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
- DenikitugGS-1811, DENPhase 22 trials
Gilead Sciences · Advanced Microsatellite Stable Colorectal Cancer, HER2-negative, Gastroesophageal Junction
- DFV890Phase 22 trials
Novartis · Coronary Heart Disease, Symptomatic Knee Osteoarthritis
- DibotatugDR-01Phase 22 trials
Dren Bio · Bone Marrow Failure Syndromes, Aplastic Anemias, Severe Aplastic Anemia (SAA)
- DISC-0974Phase 22 trials
Disc Medicine, Inc · Anemia, Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia
- DNA VaccinePhase 22 trials
NEC Bio B.V · Triple Negative Breast Cancer, Malignant Melanoma, Melanoma (Skin)
- DNL151BIIB122Phase 22 trials
Denali Therapeutics Inc. · Parkinson Disease
- DOC1021Phase 22 trials
Diakonos Oncology Corporation · Glioblastoma (GBM), Refractory Melanoma
- Dositinib mesylatePhase 22 trials
Henan Genuine Biotech Co., Ltd. · Non-Small Cell Lung Cancer
- DS-3939aPhase 22 trials
Daiichi Sankyo · Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
- DS-8201Phase 22 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Breast Cancer, Advanced Solid Tumor
- DS010Phase 22 trials
Dartsbio Pharmaceuticals Ltd. · Cancer, Cachexia
- DSP107Phase 22 trials
Kahr Bio Australia Pty Ltd · Colorectal Cancer, Advanced Solid Tumor, Non Small Cell Lung Cancer
- DT-101Phase 22 trials
Draig Therapeutics Ltd · Major Depressive Disorder (MDD)
- Dual-target CAR-NK cell productPhase 22 trials
Beijing Biotech · Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Carcinoma
- DZD6008Phase 22 trials
Dizal Pharmaceuticals · Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer
- EB-DART-NK01DLL3, CD56 CAR-NK cellsPhase 22 trials
Beijing Biotech · Small Cell Lung Cancer (SCLC), Relapsed/Refractory SCLC, Extensive-stage SCLC
- EB-DNK101 dual-targeting CAR-NK cellsMSLN + MUC1Phase 22 trials
Beijing Biotech · Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced or Metastatic Disease, Unresectable Locally Advanced
- EB-DNK102 dual-targeting CAR-NK cellsCLDN18.2 + MUC1Phase 22 trials
Beijing Biotech · Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced or Metastatic Disease, Unresectable Locally Advanced
- EB-DUO-CAR-NK-CEAGCCPhase 22 trials
Beijing Biotech · Colorectal Cancer Metastatic, Adenocarcinoma of Colon, Colorectal Cancer
- ECC4703Phase 22 trials
Eccogene · Adult Obesity, Weight Management, Metabolic Dysfunction-associated Steatohepatitis
- EDP167Phase 22 trials
Eddingpharm (Zhuhai) Co., Ltd. · Mixed Dyslipidemia, Homozygous Familial Hypercholesterolemia (HoFH)
- EfinopegdutideMK-6024, HM12525APhase 22 trials
Merck & Co. · Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic
- EG110APhase 22 trials
Cyllene Therapeutics · Neurogenic Detrusor Overactivity, Spinal Cord Injuries, Urinary Bladder, Overactive
- EltrekibartLY3041658Phase 22 trials
Eli Lilly · Ulcerative Colitis, Ulcerative Colitis Chronic, Hidradenitis Suppurativa
- EmavusertibCA-4948Phase 22 trials
Curis, Inc. · Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma
- EN001 Allogeneic early-passage Wharton's jelly-derived mesenchymal stem cellsWJ-MSCs, EN001Phase 22 trials
ENCell · Sarcopenia, Charcot-Marie-Tooth Disease Type 1A
- endoxifenPhase 22 trials
Atossa Therapeutics, Inc. · Precocious Puberty, Gonadotropin-dependent, Breast Neoplasms, Invasive Breast Cancer
- EnicepatideCT-388, RO7795068Phase 22 trials
Carmot Therapeutics, Inc. · Obesity, Overweight, Overweight or Obese
- EnobosarmPhase 22 trials
Veru Inc. · Obesity & Overweight, Mobility Disability, HOMA-IR
- ENTR-601-44Phase 22 trials
Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)
- ENTR-601-45Phase 22 trials
Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.